PRO 140, a monoclonal antibody targeting CCR5, as a...

  • Main
  • 2018 / 04
  • PRO 140, a monoclonal antibody targeting CCR5, as a...
HIV Clinical Trials 2018 / 04

PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection

Dhody, Kush, Pourhassan, Nader, Kazempour, Kazem, Green, Derry, Badri, Shide, Mekonnen, Hana, Burger, Denis, Maddon, Paul J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
HIV Clinical Trials
DOI:
10.1080/15284336.2018.1452842
Date:
April, 2018
File:
PDF, 1017 KB
english, 2018
Conversion to is in progress
Conversion to is failed